Loading clinical trials...

What Factors Are Associated With Prognosis of Rotator Cuff Disorder After Subacromial Hyaluronic Acid Injection | Clinical Trials | Clareo Health

UNKNOWNNA

What Factors Are Associated With Prognosis of Rotator Cuff Disorder After Subacromial Hyaluronic Acid Injection

NCT03677895•Taipei Veterans General Hospital, Taiwan

View on ClinicalTrials.gov

Summary

To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients

Detailed Description

Objective: To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients and also investigate the factors associated with clinically important improvement after subdeltoid hyaluronic acid for rotator cuff disorder. Design: Prospective, longitudinal comparison study. Participants: Patients with rotator cuff disease Intervention: Three subacromial injection with hyaluronic acid with 2 week-interval. Main Outcome Measures: Visual analog scale (VAS) of the shoulder pain, Constant score, SPADI score, and angles of active shoulder range of motion (flexion, abduction, external rotation, and internal rotation) at pre-treatment, post-treatment at week 4 and post-treatment at week 12.

Eligibility

Age

20 - 90 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. with clinically and ultrasonographically diagnosed rotator cuff disease of the shoulder-impingement, tendinosis and tear;
•2. who reported shoulder pain more than 3 months;

Exclusion Criteria

•1. presence of another medical or psychological condition, including cancer, rheumatoid arthritis, endocrine disease (i.e., diabetes), major depression, or schizophrenia;
•2. previous major trauma history at currently affected shoulder; 3 primary osteoarthritis of the glenohumeral joint in a simple radiograph; 4previous injection history at the affected shoulder within 3 months

Locations (1)

Taipei Veterans General Hospital

Taipei, Taiwan

Key Dates

Start Date

October 8, 2018

Primary Completion Date

March 1, 2019

Completion Date

March 1, 2019

Last Updated

October 10, 2018

Enrollment

200

ESTIMATED participants

Conditions

Rotator Cuff Impingement Syndrome

Interventions

Hyaluronic Acid

DRUG

Contacts

Jia Chi Wang, MD

CONTACT

886-2-28757361 jcwang0726@gmail.com

Clinical Applications of Blood Flow Restriction and Rehabilitation Outcomes

NCT04989023

Knee Pain ChronicAnterior Knee Pain Syndrome+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions